This directory serves as a resource listing of active biotech that develop therapeutics, diagnostics and/or medtech. The companies listed in this directory are not representative of the companies that are active members of the Biotech and Money community.
Add / Amend your company listing for free
(only active biotech ie. therapeutic, diagnostic and medtech companies are eligible for listing)
Taiwan
CYbiotech produces medications for the digestive system, immune system and well-being.
HenKan Pharmaceutical Company is a specialty pharmaceutical company focused on acquiring pharmaceutical products for clinical and commercial development in Asia, including Taiwan, China and Korea. Their product portfolio includes HK-01 for cancer targeting solid tumor; HK-02 an immuno therapy cancer product; and HK-03, a novel form of narcotic analgesics.
Medigen Biotechnology Corp. engages in the development of therapeutics for liver and cancer diseases in Taiwan. Its product portfolio includes PI-88, which is in Phase III clinical trials for reducing tumor recurrence after surgical resection of early hepatocellular carcinoma (HCC); and Telomelysin, a novel oncolytic virotherapy for head and neck cancers, and HCC treatment.
Meridigen is a drug discovery and translational research and development organization primarily focused on the discovery and development of molecular targeted therapies using stem cell technology and protein therapeutics.
It is headquarted in Taipei, Taiwan and has main operation office in China.
It is headquarted in Taipei, Taiwan and has main operation office in China.
The company are a biotech start-up focusing on innovative oncology drug development. Their lead product is a carbohydrate based immunotherpy for various cancer indications. Their lead project is a phase ii/iii multi-national study for metastatic breast cancer. The company are currently planning to start a global phase III study next year.
In addition, the company also have a glyco-array for cancer screening using Their carbohydrate technology.
In addition, the company also have a glyco-array for cancer screening using Their carbohydrate technology.
PharmaEngine, Inc. focuses on the development of new drugs for the treatment of cancer and Asian prevalent diseases. Company's product PEP02 is a novel and highly stable nanoliposomal formulation of irinotecan.
PharmaEssentia Corporation is a pharmaceutical company established by a group of Taiwanese-American scientists. The company's mission is to discover, develop, and bring to the market of efficacious, safe and cost-effective therapeutic products for human disease. The company's novel PEGylation technology platform consists of a combination of Protein Engineering and PEGylation chemistry.
SunTen Phytotech (STPT) strives to be a recognized industry leader in new drug development and one of the most admired pharmaceutical companies. They are dedicated in the translation and the development of new targets and molecules that address unmet needs in neurology, oncology and inflammatory diseases.
TaiGen Biotechnology is a research-based and product-driven pharmaceutical company engaging in the development of novel therapeutics for infectious diseases, cancer and diabetes-related complications. The company's products include anti-infective drugs for community acquired pneumonia, diabetic foot infection, urinary track infection, and hospital acquired pneumonia; stem cell mobilizer products for limb ischemia, stem cell transplantation, and AMD/diabetic retinopathy; and anti-HCV and cancer products.
Taiwan Liposome Company (TLC) is a specialty biopharmaceutical company focused on research, development, and commercialization of products based on its proprietary drug delivery technologies to improve treatments of cancer, peripheral arterial disease (PAD), age-related macular degeneration (AMD) and infectious diseases. Company's strength is optimizing pharmacokinetics with lipid-based nanoparticles formulations to improve efficacy and reduce toxicity.